Xin Deng

Dr. Xin Deng

School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Acta Biomaterialia
Verified
Journal Article
Closed access
XLXue Li
Xue Li
MFMian Fu
Mian Fu
JWJun Wu
Jun Wu
CZChenyu Zhang
Chenyu Zhang
XDXin Deng
Xin Deng
LGLiang Ge
Liang Ge

1 March 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XDXin Deng
Xin Deng
RMRuiyao Mai
Ruiyao Mai
CZChenyu Zhang
Chenyu Zhang
DYDianbao Yu
Dianbao Yu
YRYichang Ren
Yichang Ren
JCJianjun Chen
Jianjun Chen

5 March 2015 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
BYBaowei Yang
Baowei Yang
XLXue Li
Xue Li
CZChenyu Zhang
Chenyu Zhang
SYSijia Yan
Sijia Yan
WWWei Wei
Wei Wei
WHWenlong Huang
Wenlong Huang
Three series of Momordica charantia (MC)2 analogues were designed, synthesized and evaluated for their anti-hyperglycaemic effects. Alanine scanning focusing on the peptide MC2 indicated the importance of the residues proline (Pro)3, serine (Ser)6, isoleucine (Ile)7 and Ser10 for anti-hyperglycaemic effects. Among the first series of MC2 analogues, peptide I-4 exhibited a better anti-hyperglycaemic effect and was chosen for further modification. A further two series of conformationally constrained analogues were designed by scanning the residues Pro3, Ser6, Ile7, and Ser10 with an i − (i + 2) lactam bridge consisting of a glutamic acid-Xaa-lysine (Glu-Xaa-Lys) scaffold and a diproline fragment. By screening in normal mice and mice with diabetes mellitus, peptides II-1, II-2 and III-3 showed a significant improvement in anti-hyperglycaemic and anti-oxidative activities compared with I-4. These data suggest that II-1, II-2 and III-3 could be candidates for future treatment of diabetes mellitus.

1 January 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XDXin Deng
Xin Deng
QQQianqian Qiu
Qianqian Qiu
BYBaowei Yang
Baowei Yang
XWXuekun Wang
Xuekun Wang
WHWenlong Huang
Wenlong Huang
HQHai Qian
Hai Qian

24 December 2024 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HHHaiqi He
Haiqi He
XDXin Deng
Xin Deng
ZWZhijie Wang
Zhijie Wang
JCJianjun Chen
Jianjun Chen

11 January 2017 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
XDXin Deng
Xin Deng
XLXue Li
Xue Li
WCWei Chen
Wei Chen
TZTianxiao Zhao
Tianxiao Zhao
WHWenlong Huang
Wenlong Huang
HQHai Qian
Hai Qian